Email updates

Keep up to date with the latest news and content from BMC Developmental Biology and BioMed Central.

Open Access Highly Accessed Methodology article

Development of antibodies to human embryonic stem cell antigens

Jingli Cai1, Judith M Olson2, Mahendra S Rao1, Marisa Stanley2, Eva Taylor2 and Hsiao-Tzu Ni2*

Author Affiliations

1 Stem Cell Biology Unit, Laboratory of Neurosciences, National Institute on Aging, 333 Cassell Dr, Rm406A, Baltimore, MD 21224, USA

2 Stem Cell Department, R&D Systems, Inc., 614 McKinley Place. Minneapolis, MN 55413, USA

For all author emails, please log on.

BMC Developmental Biology 2005, 5:26  doi:10.1186/1471-213X-5-26


The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-213X/5/26


Received:26 April 2005
Accepted:29 November 2005
Published:29 November 2005

© 2005 Cai et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Using antibodies to specific protein antigens is the method of choice to assign and identify cell lineage through simultaneous analysis of surface molecules and intracellular markers. Embryonic stem cell research can be benefited from using antibodies specific to transcriptional factors/markers that contribute to the "stemness" phenotype or critical for cell lineage.

Results

In this report, we have developed and validated antibodies (either monoclonal or polyclonal) specific to human embryonic stem cell antigens and early differentiation transcriptional factors/markers that are critical for cell differentiation into definite lineage.

Conclusion

These antibodies enable stem cell biologists to conveniently identify stem cell characteristics and to quantitatively assess differentiation.

Background

Although the stem cell concept was introduced decades ago, to date, stem cells can only be defined functionally, not morphologically or phenotypically. Two functions define stem cells. Firstly, they are self-renewing, thus able to propagate to generate additional stem cells. Secondly they can differentiate into various progenitor cells, which commit to further maturation along a specific lineage. While stem cells can be best defined functionally, a good number of molecular markers have been used to prospectively identify various stem cell populations. Although the functional importance of many of these antigens remains unknown, their unique expression pattern and timing of expression provide a useful tool for scientists to identify as well as isolate stem cells.

Embryonic stem cells (ESC), derived from the inner cell mass of pre-implantation embryos, have been recognized as the earliest stem cell population [1,2]. This pluripotent population can differentiate into all somatic tissue including germ cells. In the case of human ESC, they can differentiate into some extra-embryonic derivatives as well. Like mouse ESC, human ES cells can be maintained and propagated on mouse fibroblast feeders for extended periods in media containing basic fibroblast growth factor (bFGF) [3]. Gene expression of undifferentiated human ES cells has been investigated among several ES cell lines by a variety of techniques. They include comparison with databases, reverse transcriptase-polymerase chain reaction, focused cDNA microarrays, and immunocytochemistry. A list of molecules comprised of known ES-specific or -highly expressed genes and candidates that can serve as markers for human ESCs and may also contribute to the "stemness" phenotype has been established [3-11]. For example, pluripotent ESC can be characterized by high level expression of Oct3/4 (POU domain, class 5, transcription factor 1, Pou5f1) and Nanog, which are a member of POU domain and homeobox transcription factors respectively. A critical amount of Oct3/4 and Nanog expression is required to sustain stem-cell pluripotency and both of these markers are downregulated as cells differentiate in vitro and in vivo [4-9]. Antibodies to Oct3/4 which cross react with human Oct 3/4 have been widely used to monitor the presence of undifferentiated ESC.

No single marker however is sufficient or unique for identifying ESCs. Oct3/4 for example is expressed by germ cells and may be expressed by specific populations later in development. Likewise, Nanog has been shown to express in other tissues. We and other have noted however, that while no single marker is sufficient a constellation of positive and negative markers can in concert unambiguously allow one to define the state of ESC cultures and that surface markers in combination can be used to prospectively sort for ESC.

Based on published data at the level of gene expression, we have cloned a number of candidate marker genes. We have also expressed the recombinant protein and generated a panel of monoclonal or polyclonal antibodies to these proteins. Using these antibodies we have confirmed the specificity and selectivity of these antibodies on several ESC lines and established their utility as stem cells markers. Our results confirm the expression pattern and timing of these cell markers at the protein level, whereas previous data reported at the level of gene expression.

Results and discussion

Characterization of undifferentiated human ES cells and differentiated EBs by antibodies

All monoclonal antibodies were initially selected for their abilities to recognize recombinant proteins in direct ELISAs. A subset were also tested by Western Blot analysis using recombinant proteins and cell lysate to confirm binding to a single epitope. The best clone was later screened for its applications for immunocytochemistry and flow cytometry using various cell lines. Human peripheral blood platelets were used for screening mouse anti-human CD9 antibody. MCF-7 cells were used for screening mouse anti-human E-Cadherin and PODXL (podocalyxin-like) antibodies. MG-63 cells were used for screening mouse anti-human GATA1 (GATA binding protein 1) antibody. Beta-TC6 cells were used for screening for mouse anti-human/mouse PDX-1 (pancreatic duodenal homeobox-1) antibody. NTERA-2 cells were used for screening mouse anti-human Oct3/4 and SOX2 (sex-determining region Y-box 2) antibodies. All polyclonal antibodies were affinity-purified using recombinant proteins and validated by direct ELISAs and Western. Caco-2 cells were used for validation of goat anti-human GATA6 antibody and NTERA-2 cells were used for validation of goat anti-human Nanog and anti-human Oct3/4 antibodies (Summarized in Table 1).

Table 1. Summary list of antibody verification by western blot.

After antibodies were validated in direct ELISAs, Western blot or cell lines (Fig. 1 and data not shown), they were used to examine the expression of individual molecules in undifferentiated human ES cells and differentiated EBs. When examined by immunohistochemistry, high level of expressions of Oct3/4, SOX2, E-Cadherin, PODXL and Nanog were observed in undifferentiated human ES cells (Fig. 2A, 2B and 2C). DPPA5 (developmental pluripotency associated 5) expression was also observed in undifferentiated human ES cells (data not shown). We noted that a subset of the proteins used were membrane bound proteins. To test if any of the antibodies generated could recognize an extracellular epitope and thus be used for live cell sorting, we repeated staining of live cells as previously described. The CD9, E-Cadherin and PODXL antibodies recognized an extracellular epitope and their ability to select cells by FACS was confirmed (Fig. 3). Minimal or no expressions of Oct3/4, E-Cadherin, PODXL and Nanog were detected in the differentiated EBs (Fig. 2D, 2E and 2F). However, SOX2 expression, which is observed in neural progenitor cells, is persistent in subsets of EBs.

thumbnailFigure 1. Western blot analysis for Gt × hOct3/4 (A), Gt × hNanog (B) and Ms × hSOX2 (C) in NTERA-2 cell lysate, Ms × hE-Cadherin (D) in MCF-7 cell lysate, Ms × hCD9 (E) in PBMC lysate and Ms × hPDX-1(F) in β-TC-6 cell lysate. Numbers indicate the positions of molecular weight markers.

thumbnailFigure 2. Undifferentiated human ES cells (A, B, and C) and differentiated EBs (D, E and F) were analyzed using antibodies to indicated molecular markers. Immunostaining with goat anti-human Oct3/4 (Red in A and D), mouse anti-human SOX2 (Green in A and D), goat anti-human E-Cadherin (Red in B and E), mouse anti-human PODXL (Green in B and E), and goat anti-human Nanog (Red in C and F), are contrasted with DAPI nuclear staining (Blue in C-F). Note the dramatic downregulation of ESC specific markers (Oct3/4, E-Cadherin, PODXL, and Nanog) in EBs. However, SOX2 expression is persistent in subsets of EB cells. Scale bars = 100 μm.

thumbnailFigure 3. Human embryonic stem cells stained with anti-CD9 (A), anti-E-Cadherin (B), and anti-PODXL (C) and antigen expression detected by a flow cytometer. The specific staining is indicated by green histogram and corresponding isotype control is indicated by black histogram.

Suspension culture with FGF withdrawal is known to induce differentiation of ES cells to all three germ layer precursors [12]. The differentiation status of the EB used here was detected to contain all germ cell markers by RT-PCR (Fig. 4). In order to examine how more antibodies can be used for characterization of early differentiation events from human ES cells, we examined the expressions of endodermal markers, SOX17, GATA6 and PDX-1, and mesodermal markers, Brachyury and GATA1, in the undifferentiated human ES cells and differentiated EBs. Expressions of SOX17, GATA6, PDX-1, Brachyury and GATA1 were not detected in undifferentiated human ES cells (data not shown). In contrast to the undifferentiated ES cells, subpopulations of SOX17-, GATA6-, Brachyury- and GATA1-positive cells were observed (Fig 4). These results suggest that both endodermal and mesodermal precursors exist in EBs with FGF withdrawal for 8 days. However, no PDX-1-positive cells were seen in EBs differentiated with the same treatment (data not shown).

thumbnailFigure 4. Differentiated EBs were analyzed by either immunocytochemistry or RT-PCR to the indicated molecular markers. (A) Immunostaining with goat anti-human SOX17 (Red), is contrasted with Fluoro Nissl nuclear staining (Green). (B) Immunostaining with goat anti-human GATA6 (Red), is contrasted with DAPI nuclear staining (Blue). (C) Immunostaining with goat anti-human brachyury (Red), is contrasted with DAPI nuclear staining (Blue). (D) Immunostaining with mouse anti-human GATA1 (Red). Note that each antibody recognizes subsets of EB cells. Scale bars = 100 μm. (E) The differentiation status of EB is detected by RT-PCR using different germ layer cell markers. Selected endoderm markers AFP, FoxA2; mesoderm markers Hand1, MSX1 and ectoderm marker Msl1 were all highly expressed in the EB samples while their expression was either undetectable or at low level in the ES samples. G3PDH was a positive control showing similar amount of RNA samples were used for analysis.

Examination of cross-reactivity of antibodies on mouse ES and differentiated cells

We have also examined the cross-reactivities of these antibodies to mouse ES cells using mouse D3 ES cell line and mouse fetal endodermal tissue. Cross-reactivity to mouse of goat anti-Oct3/4, goat anti-PDX-1, goat anti-SOX17 and mouse anti-SOX2 was detected. Minimal cross-reactivity to mouse, measured by 10% intensity to human by higher than control cells, was observed in mouse anti-CD9 and mouse anti-E-cadherin antibodies. Goat anti-Nanog and mouse anti-PODXL antibodies appear to be human-specific as well (data not shown). The subtypes of monoclonal antibodies were also identified in the best clones. These results are summarized in Table 2.

Table 2. Summary of antibodies detection in ES and EB samples.

Conclusion

The expression patterns detected using antibodies developed in our facility are consistent with data reported using reverse transcriptase-polymerase chain reaction or cDNA microarrays. Moreover several of the monoclonal antibodies have differing heavy chain subunits allowing double labeling using subtype specific markers to be performed.

In summary, we have developed a useful collection of antibodies that would be useful for identification of stem cell characteristics and assessment of differentiation. Several additional antibodies to the molecules that have been identified as potential cell lineage markers [13] are currently under development using the same approach.

Methods

Cloning and expression of Brachyury, DPPA5, CD9, E-Cadherin, GATA1, GATA6, Nanog, Oct3/4, PDX-1, PODXL, SOX2 and SOX17

Brachyury (aa. 1–202), DPPA5 (a.a. 1–116), GATA1 (a.a. 1–413), GATA6 (aa. 1–449), Nanog (aa. 153–305), Oct3/4 (aa. 1–265), PDX-1 (aa. 1–283), SOX2 (aa. 135–317) and SOX17 (aa. 177–414) were expressed in E. Coli and extracellular domains of CD9, E-Cadherin, PODXL were expressed in mouse NSO cells. All proteins were purified and sequenced before they were used as antigens for immunizations and as substrate for antibody screening and subcloning.

Production and purification of antibodies

All monoclonal antibodies were derived from fusions of mouse myeloma with B cells obtained from BALB/c mice which had been immunized with purified antigen. The IgG fraction of the culture supernatant was purified by Protein G affinity chromatography (Sigma). Each panel of antibodies was screened and selected for their abilities to detect purified recombinant antigen in direct ELISA and Western blot. All polyclonal antibodies were derived from sera of goats which had been immunized and boost it with purified antigen. Antibody was purified from the sera by an antigen-affinity chromatography.

Cells and cell culture

Human Caco-2, MG-63, MCF-7, NTERA-2 and mouse D3 cells were purchased from American Type Culture Collection (ATCC). Cells were cultured according to the ATCC instructions. Information regarding human ES cell line HSF-6 (NIH code UC06) can be obtained at the website [14]. Undifferentiated human ES cells were cultured according to the protocol provided by the University of California, San Francisco in human ES culture medium [DMEM supplemented with 20% KnockOut Serum Replacement (Invitrogen) and 5 ng/mL of bFGF (R&D Systems)]. To induce formation of embryoid bodies (EBs), ES colonies were harvested, separated from the MEF feeder cells by gravity, gently resuspended in ES culture medium and transferred to non-adherent suspension culture dishes (Corning). Unless otherwise noted, EBs derived from human ES cell aggregates were cultured for 8 days in ES culture medium deprived of bFGF and used for analysis by immunohistochemistry as described.

Western blot

Cells are solubilized in hot 2× SDS gel sample buffer (20 mM dithiothreitol, 6% SDS, 0.25 M Tris, pH 6.8, 10% glycerol, 10 mM NaF and bromophenyl blue) at 2 × 106 per mL. The extracts are heated in a boiling water bath for 5 minutes and sonicated with a probe sonicator with 3–4 bursts of 5–10 seconds each. Samples are diluted with 1× SDS sample buffer to the desired loading of 1–5 × 103 per lane. Lysates were resolved by SDS-PAGE, transferred to Immobilon-P membrane, and immunoblotted with 0.5 μg/mL primary Abs as described in R&D Systems Website [15].

Immunohistochemistry

Antibodies were used with the appropriate secondary reagents at a concentration of 5 to 10 μg/ml. Cells or sections of EBs were fixed with 4% paraformaldehyde in PBS at room temperature for 20 min, then blocked and permeabilized with 0.1% Triton X-100, 1% BSA, 10% normal donkey serum in PBS at room temperature for 45 min. After blocking, cells were incubated with diluted primary antibody overnight at 4°C followed by coupled anti-mouse or anti-goat IgG (Molecular Probes) at room temperature in the dark for an hour. Between each step cells were washed with PBS with 0.1% BSA.

RT-PCR

Total RNA was extracted from EBs using Trizol LS (Invitrogen). cDNA was synthesized by using Superscript II reverse transcriptase (Invitrogen) according to the manufacturer's recommendations. The PCR primers are available upon request.

Flow cytometry

Antibodies were prepared at the concentration of 0.1 mg/mL. 10 μL of the stock solution was added to 1 – 2.5 × 105 cells in a total reaction volume not exceeding 200 μL. The sample was then incubated for 20 min at 2–8 °C. Following incubation, excess antibody was removed by washing cells twice with FACS buffer (2% FCS and 0.1% sodium azide in Hank's buffer). After wash, cells were resuspend in 200 μL of FACS buffer and the binding of unlabeled monoclonal antibodies was visualized by adding 10 μL of a 25 μg/mL stock solution of a secondary developing reagent such as goat anti-mouse IgG conjugated to a fluorochrome for 20 min at 2–8°C. Following incubation, cells were washed once with FACS buffer, once with PBS. After wash, cells were resuspend in 400 μL of PBS and analyzed on a FACScant flow cytometer (Becton-Dickinson, Mountain View, CA). Five thousand events were collected and analyzed using CELL Quest software.

Authors' contributions

Dr. Cai contributed significantly in validating antibodies in human ES cells and human EBs. Ms. Olson performed initial screening of antibodies in various cell lines. Dr. Rao initiated the project, supervised Dr. Cai, and participated in all discussions for this report. Ms. Stanley and Ms. Taylor performed Western blot analysis. Dr. Ni coordinated collaborative work between two labs, monitored the generation of the antibodies, and directed the project at R&D Systems.

Acknowledgements

We are grateful to Drs. M. Tsang and J.H. Kim for their valuable advice and assistance.

References

  1. Evans MJ, Kaufman MH: Establishment in culture of pluripotential cells from mouse embryos.

    Nature 1981, 292:154-156. PubMed Abstract | Publisher Full Text OpenURL

  2. Martin GR: Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.

    Proc Natl Acad Sci U S A 1981, 78:7634-7638. PubMed Abstract | PubMed Central Full Text OpenURL

  3. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM: Embryonic stem cell lines derived from human blastocysts.

    Science 1998, 282:1145-1147. PubMed Abstract | Publisher Full Text OpenURL

  4. Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PW, Staudt LM: A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo.

    Nature 1990, 345:686-692. PubMed Abstract | Publisher Full Text OpenURL

  5. Niwa H, Miyazaki J, Smith AG: Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells.

    Nat Genet 2000, 24:372-376. PubMed Abstract | Publisher Full Text OpenURL

  6. Pesce M, Scholer HR: Oct-4: gatekeeper in the beginnings of mammalian development.

    Stem Cells 2001, 19:271-278. PubMed Abstract | Publisher Full Text OpenURL

  7. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A: Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells.

    Cell 2003, 113:643-655. PubMed Abstract | Publisher Full Text OpenURL

  8. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S: The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells.

    Cell 2003, 113:631-642. PubMed Abstract | Publisher Full Text OpenURL

  9. Cavaleri F, Scholer HR: Nanog: a new recruit to the embryonic stem cell orchestra.

    Cell 2003, 113:551-552. PubMed Abstract | Publisher Full Text OpenURL

  10. Pera MF, Filipczyk AA, Hawes SM, Laslett AL: Isolation, characterization, and differentiation of human embryonic stem cells.

    Methods Enzymol 2003, 365:429-446. PubMed Abstract OpenURL

  11. Bhattacharya B, Miura T, Brandenberger R, Mejido J, Luo Y, Yang AX, Joshi BH, Ginis I, Thies RS, Amit M, Lyons I, Condie BG, Itskovitz-Eldor J, Rao MS, Puri RK: Gene expression in human embryonic stem cell lines: unique molecular signature.

    Blood 2004, 103:2956-2964. PubMed Abstract | Publisher Full Text OpenURL

  12. Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M, Soreq H, Benvenisty N: Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers.

    Mol Med 2000, 6:88-95. PubMed Abstract OpenURL

  13. Brandenberger R, Wei H, Zhang S, Lei S, Murage J, Fisk GJ, Li Y, Xu C, Fang R, Guegler K, Rao MS, Mandalam R, Lebkowski J, Stanton LW: Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.

    Nat Biotechnol 2004, 22:707-716. PubMed Abstract | Publisher Full Text OpenURL